Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publications/12143-high-dose-carfilzomib-achieves-superior-anti-tumor-activity-over-low-dose-and-recaptures-response-in-relapsedrefractory-multiple-myeloma-resistant-to-lowdose-carfilzomib-by-co-inhibiting-the-v2-and-v1-subunits-of-the-proteasome-complex/authors?page=4